Please ensure Javascript is enabled for purposes of website accessibility

pharma

AstraZeneca CEO Pascal Soriot and then-Gov. Glenn Youngkin announced the company’s planned $4.5 billion plants in October 2025. Photo by Kaitlyn DeHarde, Office of Gov. Glenn Youngkin
Mar 2, 2026

Preparation, pandemic helped Virginia land Big Pharma deals

Virginia attracted $12 billion in pharmaceutical manufacturing investments in 2025, leveraging site readiness, workforce training, and strong infrastructure.

The Merck logo is seen at a gate to the Merck & Co. campus in Rahway, New Jersey, on July 12, 2018. Photo by Reuters/Brendan McDermid.
Feb 24, 2026

Merck to create separate cancer division as Keytruda patent loss looms

Merck is creating a distinct cancer division anchored by Keytruda before its patents expire and splitting its human health division in two.

2022 Virginia 500: Moving up
Nov 30, 2025

2025: The year of living disruptively

Looking back on 2025, the best symbol of the past year’s upheaval might be the White House, if not its most famous occupant. Since moving back into 1600 Pennsylvania Ave. in January, our real estate mogul president has launched into a series of home renovations worthy of its own HGTV series. The most prominent changes […]

PAUL MANNING
Nov 2, 2025

PAUL MANNING

CHAIRMAN AND CEO PBM CAPITAL GROUP CHARLOTTESVILLE

Gov. Glenn Youngkin signed on Oct. 31, 2025, a memorandum of understanding with AstraZeneca, Eli Lilly, Merck and state entities to establish a training center. Photo by Katherine Schulte/Virginia Business
Oct 31, 2025

AstraZeneca, Eli Lilly, Merck commit $120M to Virginia pharma training

AstraZeneca, Eli Lilly and Merck committed $120 million to develop an advanced pharmaceutical manufacturing training center in Central Virginia.

A worker at Merck's Elkton facility. Copyright Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved.
Oct 20, 2025

Merck to build $3B facility in Elkton

Merck & Co. is starting construction on a $3 billion pharmaceutical manufacturing facility in Elkton that is expected to create 500 jobs.

Default Alt Text
Oct 17, 2025

Civica to start selling long-acting insulin in January 2026

Civica will begin selling a type of insulin on Jan. 1, 2026, although it will not come from the nonprofit drug maker’s Petersburg facility.

AstraZeneca plans multibillion-dollar pharma factory in Virginia
Oct 9, 2025

AstraZeneca to invest $4.5B in Albemarle manufacturing plants

AstraZeneca will invest $4.5 billion to establish two new manufacturing facilities in Albemarle County and create 600 direct jobs.

Eli Lilly Chair and CEO Dave Ricks speaks at a news conference in Richmond on Sept. 16, 2025, announcing the pharmaceutical company's $5 billion investment in a new manufacturing plant in Goochland County. Photo by Katherine Schulte
Sep 16, 2025

Eli Lilly to invest $5B in Goochland plant, creating 650 jobs

Pharmaceutical giant Eli Lilly & Co. plans to invest $5 billion in a manufacturing facility in Goochland County expected to create 650 permanent jobs.

Health Care 2025: JACKSON, REESE
Sep 2, 2025

Health Care 2025: JACKSON, REESE

Since 2016, Jackson has led Chesapeake Regional Healthcare, which includes the Chesapeake Regional Medical Center and more than 40 practice locations, as well as about 600 physicians serving Hampton Roads. In early April, the hospital opened a psychiatric emergency room, the first on Hampton Roads’ south side, and at the end of the month, the […]

Health Care 2025: JEVSEVAR, DR. DAVID S.
Sep 2, 2025

Health Care 2025: JEVSEVAR, DR. DAVID S.

In 2022, Jevsevar became CEO of OrthoVirginia, the largest independent orthopedic practice in the state, with 155-plus orthopedic specialist physicians across more than 35 locations in Lynchburg, Northern Virginia, Richmond, Southwest Virginia and Hampton Roads. The practice, which is the official orthopedic and sports medicine provider of the Washington Commanders, turns 10 this year. An [&hellip[...]

Health Care 2025: PESICKA, EDWARD A.
Sep 1, 2025

Health Care 2025: PESICKA, EDWARD A.

Pesicka became CEO of Fortune 500 health care logistics and supply company Owens & Minor in 2019. In 2023, he announced a five-year strategic plan for the company to increase profits and reduce costs. Owens & Minor reported $10.7 billion in fiscal 2024 revenue, up from $10.3 billion in 2023. The company has been engaged […]

YOUR NEWS.
YOUR INBOX.
DAILY.

By subscribing you agree to our Privacy Policy.